Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer von Fong, Lawrence, Hotson, Andrew, Powderly, John D., Sznol, Mario, Heist, Rebecca S., Choueiri, Toni K., George, Saby, Hughes, Brett G. M., Hellmann, Matthew D., Shepard, Dale R., Rini, Brian I., Kummar, Shivaani, Weise, Amy M., Riese, Matthew J., Markman, Ben, Emens, Leisha A., Mahadevan, Daruka, Luke, Jason J., Laport, Ginna, Brody, Joshua D., Hernandez-Aya, Leonel, Bonomi, Philip, Goldman, Jonathan W., Berim, Lyudmyla, Renouf, Daniel J., Goodwin, Rachel A., Munneke, Brian, Ho, Po Y., Hsieh, Jessica, McCaffery, Ian, Kwei, Long, Willingham, Stephen B., Miller, Richard A.

Volltext

Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors von Janku, Filip, Zhang, Halle Huihong, Pezeshki, Abdulmohammad, Goel, Sanjay, Murthy, Ravi, Wang-Gillam, Andrea, Shepard, Dale R., Helgason, Thorunn, Masters, Tyler, Hong, David S., Piha-Paul, Sarina A., Karp, Daniel D., Klang, Mark, Huang, Steven Y., Sakamuri, Divya, Raina, Anjali, Torrisi, Jean, Solomon, Stephen B., Weissfeld, Alice, Trevino, Ernest, DeCrescenzo, Gary, Collins, Amanda, Miller, Maria, Salstrom, Jennifer L., Korn, Ronald L., Zhang, Linping, Saha, Saurabh, Leontovich, Alexey A., Tung, David, Kreider, Brent, Varterasian, Mary, Khazaie, Khashayarsha, Gounder, Mrinal M.

Volltext

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial von Rini, Brian I, Prof, Dorff, Tanya B, MD, Elson, Paul, ScD, Rodriguez, Cristina Suarez, MD, Shepard, Dale, MD, Wood, Laura, MSN, Humbert, Jordi, BSc, Pyle, Linda, RN, Wong, Yu-Ning, MD, Finke, James H, Prof, Rayman, Patricia A, MS, Larkin, James M G, FRCP, Garcia, Jorge A, MD, Plimack, Elizabeth R, MD

Volltext

Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor von James, Angela Joubert, Smith, Catherine C., Litzow, Mark, Perl, Alexander E., Altman, Jessica K., Shepard, Dale, Kadokura, Takeshi, Souda, Kinya, Patton, Melanie, Lu, Zheng, Liu, Chaofeng, Moy, Selina, Levis, Mark J., Bahceci, Erkut

Volltext

Prospective Clinical Study of Precision Oncology in Solid Tumors von Sohal, Davendra P S, Rini, Brian I, Khorana, Alok A, Dreicer, Robert, Abraham, Jame, Procop, Gary W, Saunthararajah, Yogen, Pennell, Nathan A, Stevenson, James P, Pelley, Robert, Estfan, Bassam, Shepard, Dale, Funchain, Pauline, Elson, Paul, Adelstein, David J, Bolwell, Brian J

Volltext

Open‐label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment von Saif, Muhammad Wasif, Rosen, Lee, Rudek, Michelle A., Sun, Weijing, Shepard, Dale R., Becerra, Carlos, Yamashita, Fumiaki, Bebeau, Paul, Winkler, Robert

Volltext

A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors von Cohen, Ezra E. W., Pishvaian, Michael J., Shepard, Dale R., Wang, Ding, Weiss, Jared, Johnson, Melissa L., Chung, Christine H., Chen, Ying, Huang, Bo, Davis, Craig B., Toffalorio, Francesca, Thall, Aron, Powell, Steven F.

Volltext

Salvage stereotactic body radiation therapy re‐irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report von Buchberger, David S., Cook, Samantha K., Anderson, Peter M., Shepard, Dale R., Ku, Jamie A., Fritz, Michael A., Sindwani, Raj, Recinos, Pablo, Murphy, Erin S., Koyfman, Shlomo A.

Volltext

Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue Sarcoma von Lawrenz, Joshua M., Vega, Jose F., George, Jaiben, Curtis, Gannon L., Gordon, Jaymeson, Maggiotto, Amanda, Tullio, Katherine, Shepard, Dale R., Reith, John D., Schwartz, Herbert S., Nystrom, Lukas M., Mesko, Nathan W.

Volltext

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment von Saif, Muhammad Wasif, Becerra, Carlos R., Fakih, Marwan G., Sun, Weijing, Popovic, Lazar, Krishnamurthi, Smitha, George, Thomas J., Rudek, Michelle A., Shepard, Dale R., Skopek, Jiri, Sramek, Vladimir, Zaric, Bojan, Yamamiya, Ikuo, Benhadji, Karim A., Hamada, Kensuke, He, Yaohua, Rosen, Lee

Volltext

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors von Gupta, Neeraj, Zhang, Steven, Pusalkar, Sandeepraj, Plesescu, Mihaela, Chowdhury, Swapan, Hanley, Michael J., Wang, Bingxia, Xia, Cindy, Zhang, Xiaoquan, Venkatakrishnan, Karthik, Shepard, Dale R.

Volltext

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme von Peereboom, David M., Shepard, Dale R., Ahluwalia, Manmeet S., Brewer, Cathy J., Agarwal, Neeraj, Stevens, Glen H. J., Suh, John H., Toms, Steven A., Vogelbaum, Michael A., Weil, Robert J., Elson, Paul, Barnett, Gene H.

Volltext

A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors von Michaelson, M. Dror, Gupta, Shilpa, Agarwal, Neeraj, Szmulewitz, Russell, Powles, Thomas, Pili, Roberto, Bruce, Justine Yang, Vaishampayan, Ulka, Larkin, James, Rosbrook, Brad, Wang, Erjian, Murphy, Danielle, Wang, Panpan, Lechuga, Maria Josè, Valota, Olga, Shepard, Dale R.

Volltext

Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database von Curtis, Gannon L., Lawrenz, Joshua M., George, Jaiben, Styron, Joe F., Scott, Jacob, Shah, Chirag, Shepard, Dale R., Rubin, Brian, Nystrom, Lukas M., Mesko, Nathan W.

Volltext

Who Needs What? Perceptions of Patients and Caregivers in Oncology Phase 1 Trials von Rezash, Victoria, Reed, Janice, Gedeon, Barbara, Parsons, Eric, Siedlecki, Sandra, Daniels, Bradley, Shepard, Dale R

Volltext

Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone Sarcoma von Nystrom, Lukas M., Mesko, Nathan W., Rubin, Brian P., Shepard, Dale R., Anderson, Peter M., Jin, Yuxuan, George, Jaiben, Curtis, Gannon L., Featherall, Joseph, Lawrenz, Joshua M., Reith, John D.

Volltext

640 The combination of COM701 + nivolumab demonstrates preliminary antitumor activity in patients with metastatic breast cancer von Dumbrava, Ecaterina, Chmielowski, Bartosz, Shepard, Dale, Vaena, Daniel, Rasco, Drew, Sharma, Manish, Hamilton, Erika, Papadopoulos, Kyriakos P, Wang, Judy S, Ophir, Eran, Ferre, Pierre, Barbiro, Inbal, Cojocaru, Gady, Adewoye, Adeboye H, Patel, Manish

Volltext

Phase 1 dose expansion and biomarker study assessing first-in-class tumor microenvironment modulator VT1021 in patients with advanced solid tumors von Chen, Jian Jenny, Vincent, Melanie Y., Shepard, Dale, Peereboom, David, Mahalingam, Devalingam, Battiste, James, Patel, Manish R., Juric, Dejan, Wen, Patrick Y., Bullock, Andrea, Selfridge, Jennifer Eva, Pant, Shubham, Liu, Joyce, Li, Wendy, Fyfe, Susanne, Wang, Suming, Zota, Victor, Mahoney, James, Watnick, Randolph S., Cieslewicz, Michael, Watnick, Jing

Volltext

Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database von Mesko, Nathan W., Nystrom, Lukas M., Shepard, Dale R., Zahler, Stacey, Anderson, Peter M., George, Jaiben, Styron, Joseph F., Curtis, Gannon L., Lawrenz, Joshua M., Rubin, Brian P.

Volltext

Lack of pharmacokinetic drug–drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors von Chow, Laura Q. M., Smith, David C., Tan, Antoinette R., Denlinger, Crystal S., Wang, Ding, Shepard, Dale R., Chaudhary, Archana, Lin, Yong, Gao, Ling

Volltext